0001179110-11-009087.txt : 20110601
0001179110-11-009087.hdr.sgml : 20110601
20110601190017
ACCESSION NUMBER: 0001179110-11-009087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110527
FILED AS OF DATE: 20110601
DATE AS OF CHANGE: 20110601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brinkley David L
CENTRAL INDEX KEY: 0001302445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 11886646
MAIL ADDRESS:
STREET 1: 901 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
edgar.xml
FORM 4 -
X0303
4
2011-05-27
0
0001080014
THERAVANCE INC
THRX
0001302445
Brinkley David L
THERAVANCE, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Head of Business Dev.
Common Stock
2011-05-27
4
M
0
2652
3.10
A
99148
D
Common Stock
2011-05-27
4
M
0
2789
3.10
A
101937
D
Common Stock
2011-05-27
4
M
0
52371
9.69
A
154308
D
Common Stock
2011-05-27
4
S
0
57812
25.31
D
96496
D
Common Stock
2011-05-31
4
M
0
44402
9.69
A
140898
D
Common Stock
2011-05-31
4
M
0
1039
18.37
A
141937
D
Common Stock
2011-05-31
4
S
0
51500
25.65
D
90437
D
Stock Option (Right to Buy)
3.10
2011-05-27
4
M
0
2652
0
D
2013-01-24
Common Stock
2652
0
D
Stock Option (Right to Buy)
3.10
2011-05-27
4
M
0
2789
0
D
2013-01-24
Common Stock
2789
0
D
Stock Option (Right to Buy
9.69
2011-05-27
4
M
0
52371
0
D
2014-03-29
Common Stock
52371
44402
D
Stock Option (Right to Buy)
9.69
2011-05-31
4
M
0
44402
0
D
2014-03-29
Common Stock
44402
0
D
Stock Option (Right to Buy)
18.37
2011-05-31
4
M
0
1039
0
D
2015-02-09
Common Stock
1039
15090
D
This transaction was executed in multiple trades at prices ranging from $25.22 to $25.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $25.26 to $26.17. The price reported above reflects the weighted average sale price.
Immediately exercisable
Dispositions made pursuant to a plan intended to comply with Rule 10b5-1(c).
David Brinkley
2011-06-01